Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Arzerra approved in Japan

March 26, 2013

NDA submitted for brentuximab vedotin in Japan

March 25, 2013

Prima BioMed earns grant to support development of CVac

March 22, 2013

MHC class I-restricted vaccines prove clinically active against metastatic RCC

March 22, 2013

Supplemental BLA submitted to expand Adcetris use in U.S.

March 19, 2013

A novel glycooptimized biobetter of cetuximab is well tolerated in first-in-human trials

March 18, 2013

Novel cancer peptide vaccines prepared in Japan

March 15, 2013

Activartis gives update on its anticancer immune therapy for glioma

March 14, 2013

Patrys reports additional data from phase I/IIa PAT-SM6 study

March 11, 2013

OncoMed begins dosing in phase I trial of anti-Notch 1 antibody in solid tumors

March 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...